An observational study in ARTERIAL OCCLUSIVE DISEASE, sponsored by Meshalkin Research Institute of Pathology of Circulation. Completed at 1 site in Russian Federation. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-09-08.
Sponsored by Meshalkin Research Institute of Pathology of Circulation · Observational
The purpose of this study is to determine whether the Vascular prosthesis manufactured by Electrospinning is safe with respect to the development of thrombosis.
To test the influence of the prostheses to hemostasis blood will be pumped through the vascular prosthesis or control silicone tube (both with identical inner diameter 1,7 mm) during 20 minutes at a linear velocity 10 cm/sec (corresponding to 18 ml/min). The tested prostheses (or control tubes) will be installed between two syringes with blood installed in the UTPS-1 instrument providing synchronical movement of pistons of both syringes. Installing UTPS-1 was designed and manufactured at the Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences consists of a mechanical pushers, equipped with clamps for syringes and pistons, stepper motor, electronic control unit and power supply.
UTPS-1 and polypropylene non-pyrogenic syringes filled with blood without any bulbs of air provides absence of contacts with air, pyrogens and minimize lysis of blood cells. UTPS-1 has no analogues, and does not require licensure, metrological control or obtaining of any other permits.
After pumping the blood will be separated into plasma and cell fraction according to standard laboratory methods. Primary blood (before any treatment), blood after pumping through silicon tube (control), and vascular prosthesis will be tested for hemostatic parameters.
Notification of basic and additional parameters being studied, which will be
evaluated in the study:
Description of Design of the Research: this will be prospective (are marked in section Detailed Description)
Monocentred research
Defined indicators for each prosthesis
2 hemostasis characteristics listed hereinabove in blood after 20 min circulation through silicone tube (control)
3 hemostasis characteristics listed hereinabove in blood after 20 min circulation through After the interaction with the experimental vascular prosthesis
Will be studied 4 types of vascular prostheses made by electrospinning
296 studies on the registry are indexed under Arterial Occlusive Diseases; 46 are open to participants now.
This study's enrollment of 120 is below the median of 183 across 75 observational studies indexed under Arterial Occlusive Diseases.
Browse Arterial Occlusive Diseases studies →Meshalkin Research Institute of Pathology of Circulation is the lead sponsor of 114 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
volunteers, donors
Exclusion Criteria:
PCL - polycaprolactone
Procedure: blood sampling procedure
polycaprolactone/ gelatin/poorly permeable layer;
Procedure: blood sampling procedure
PLGA/PCL/gelatin - polylactide-co-glycolide / polycaprolactone / gelatin/poorly permeable layer
Procedure: blood sampling procedure
Procedure: blood sampling procedure
30 ml of venous blood will be collected from all voluteers using a special vacuum tubes after informed consent. Blood sampling is carried out from an arm vein. All subsequent studies will be executed in the laboratory diagnostic division of Novosibirsk Research Institute of Circulation Pathology and the presence of the donors is unnecessary
Number of participants (blood samples) having a higher degree of aggregation of platelets after interaction with the prosthesis, as a sign of thrombosis. (with ristomycin, adrenaline, collagen, ADP)
percentage
Time frame: during the day
Platelet count
cells / L
Time frame: during the day
Prothrombin time
seconds
Time frame: during the day
International Normalised Ratio
Time frame: during the day
activated partial thromboplastin time
seconds
Time frame: during the day
prothrombin Quick
Time frame: during the day
thrombin time
seconds
Time frame: during the day
soluble fibrin monomer complexes
0-4mg/100ml
Time frame: during the day
free hemoglobin
g / l
Time frame: during the day
P- selectin concentrations
ng / ml
Time frame: during the day
Adhesion of blood cells on the surface of the prosthesis
microscopy
Time frame: during the day
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Meshalkin Research Institute of Pathology of Circulation